Paul Crawford

Paul Crawford

Auto-generated profile, based on publicly available information

Paul Crawford

Mike O'Callaghan Military Medical Center, Nellis Air Force Base, NV, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2009 in The Journal of the American Board of Family Medicine
Verified
Journal Article
Open access
PDF file
PCPaul Crawford
Paul Crawford
Purpose: Multiple trials in the past have shown conflicting results of whether cinnamon lowers glucose or hemoglobin A1C (HbA1C). The purpose of this study was to determine whether cinnamon lowers HbA1C in patients with type 2 diabetes. I performed a randomized, controlled trial to evaluate whether daily cinnamon plus usual care versus usual care alone lowers HbA1c.

1 May 1997 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
PCPaul Crawford
Paul Crawford
PGPeter A. Good
Peter A. Good
EGEric Gutierrez
Eric Gutierrez
JFJoshua H. Feinberg
Joshua H. Feinberg
JBJohn P. Boehmer
John P. Boehmer
LSLawrence I. Sinoway
Lawrence I. Sinoway
Crawford, Paul, Peter A. Good, Eric Gutierrez, Joshua H. Feinberg, John P. Boehmer, David H. Silber, and Lawrence I. Sinoway.Effects of supplemental oxygen on forearm vasodilation in humans. J. Appl. Physiol. 82(5): 1601–1606, 1997.—Supplemental O2reduces cardiac output and raises systemic vascular resistance in congestive heart failure. In this study, 100% O2was given to normal subjects and peak forearm flow was measured. In experiment 1, 100% O2reduced blood flow and increased resistance after 10 min of forearm ischemia (flow 56.7 ± 7.9 vs. 47.8 ± 6.7 ml ⋅ min−1⋅ 100 ml−1; P < 0.02; vascular resistance 1.7 ± 0.2 vs. 2.4 ± 0.4 mmHg ⋅ min ⋅ 100 ml ⋅ ml−1; P < 0.03). In experiment 2, lower body negative pressure (LBNP; −30 mmHg) and venous congestion (VC) simulated the high sympathetic tone and edema of congestive heart failure. Postischemic forearm flow and resistance were measured under four conditions: room air breathing (RA); LBNP+RA; RA+LBNP+VC; and 100% O2+LBNP+VC. LBNP and VC did not lower peak flow. However, O2raised minimal resistance (2.3 ± 0.4 RA; 2.8 ± 0.5 O2+LBNP+VC, P < 0.04). When O2alone ( experiment 1) was compared with O2+LBNP+VC ( experiment 2), no effect of LBNP+VC on peak flow or minimum resistance was noted, although the return rate of flow and resistance toward baseline was increased. O2reduces peak forearm flow even in the presence of LBNP and VC.

26 May 2020 in Journal of Medical Internet Research
Verified
Journal Article
Open access
RGRonald W Gimbel
Ronald W Gimbel
LRLior Rennert
Lior Rennert
PCPaul Crawford
Paul Crawford
JLJeanette R Little
Jeanette R Little
KHOA TRUONGKHOA TRUONG
KHOA TRUONG
KPKelly Palazzo
Kelly Palazzo
Background: Past mobile health (mHealth) efforts to empower type 2 diabetes (T2D) self-management include portals, text messaging, collection of biometric data, electronic coaching, email, and collection of lifestyle information.Objective: The primary objective was to enhance patient activation and self-management of T2D using the US Department of Defense’s Mobile Health Care Environment (MHCE) in a patient-centered medical home setting.Methods: A multisite study, including a user-centered design and a controlled trial, was conducted within the US Military Health System. Phase I assessed preferences regarding the enhancement of the enabling technology. Phase II was a single-blinded 12-month feasibility study that randomly assigned 240 patients to either the intervention (n=123, received mHealth technology and behavioral messages tailored to Patient Activation Measure [PAM] level at baseline) or the control group (n=117, received equipment but not messaging. The primary outcome measure was PAM scores. Secondary outcome measures included Summary of Diabetes Self-Care Activities (SDSCA) scores and cardiometabolic outcomes. We used generalized estimating equations to estimate changes in outcomes.Results: The final sample consisted of 229 patients. Participants were 61.6% (141/229) male, had a mean age of 62.9 years, mean glycated hemoglobin (HbA1c) of 7.5%, mean BMI of 32.7, and a mean duration of T2D diagnosis of 9.8 years. At month 12, the control group showed significantly greater improvements compared with the intervention group in PAM scores (control mean 7.49, intervention mean 1.77; P=.007), HbA1c (control mean −0.53, intervention mean −0.11; P=.006), and low-density lipoprotein cholesterol (control mean −7.14, intervention mean 4.38; P=.01). Both groups showed significant improvement in SDSCA, BMI, waist size, and diastolic blood pressure; between-group differences were not statistically significant. Except for patients with the highest level of activation (PAM level 4), intervention group patients exhibited significant improvements in PAM scores. For patients with the lowest level of activation (PAM level 1), the intervention group showed significantly greater improvement compared with the control group in HbA1c (control mean −0.09, intervention mean −0.52; P=.04), BMI (control mean 0.58, intervention mean −1.22; P=.01), and high-density lipoprotein cholesterol levels (control mean −4.86, intervention mean 3.56; P<.001). Significant improvements were seen in AM scores, SDSCA, and waist size for both groups and in diastolic and systolic blood pressure for the control group; the between-group differences were not statistically significant. The percentage of participants who were engaged with MHCE for ≥50% of days period was 60.7% (68/112; months 0-3), 57.4% (62/108; months 3-6), 49.5% (51/103; months 6-9), and 43% (42/98; months 9-12).Conclusions: Our study produced mixed results with improvement in PAM scores and outcomes in both the intervention and control groups. Structural design issues may have hampered the influence of tailored behavioral messaging within the intervention group.Trial Registration: ClinicalTrials.gov NCT02949037; https://clinicaltrials.gov/ct2/show/NCT02949037International Registered Report Identifier (IRRID): RR2-10.2196/resprot.6993

1 April 2014 in Pain Medicine
Verified
Journal Article
Open access
PDF file
RDRoxana Delgado
Roxana Delgado
AYAlexandra York
Alexandra York
CLCourtney Lee
Courtney Lee
CCCindy Crawford
Cindy Crawford
CBChester Buckenmaier
Chester Buckenmaier
AGActive Self-Care Therapies for Pain (PACT) Working Group
Active Self-Care Therapies for Pain (PACT) Working Group
Objectives. Chronic pain management typically consists of prescription medications or provider-based, behavioral, or interventional procedures that are

1 January 2013 in Military Medicine
Verified
Journal Article
Open access
PDF file
TRTravis C. Russell
Travis C. Russell
PCPaul F. Crawford
Paul F. Crawford
In the last 10 years, the use of ultrasound has expanded because of its portability, safety, real-time image display, and rapid data collection. Simu

1 November 2015 in The Journal of the American Board of Family Medicine
Verified
Journal Article
Open access
PDF file
DMDavid A. Moss
David A. Moss
PCPaul Crawford
Paul Crawford
Background: Sore throat is a common cause of pain in outpatient encounters. Battlefield auricular acupuncture (the placing of needles in specific points in the ear) is a modality used to treat acute pain associated with a variety of ailments. The aim of our study was to determine whether auricular acupuncture reduces pain, medication usage, and missed work hours when added to standard therapy in adult patients with acute sore throat. Methods: We conducted an unblinded, pragmatic, randomized controlled trial among adult, nonpregnant patients presenting to an Air Force family medicine clinic with pain from acute sore throat. A total of 54 patients were followed for 48 hours after treatment. Results: Patients receiving auricular acupuncture reported lower pain scores than those who did not at 15 minutes (6.0 [95% confidence interval (CI), 5.4–6.6] vs 2.6 [95% CI, 1.7–3.5]; P < .0001), 6 hours (4.8 [95% CI, 4.0–5.6] vs 2.5 [95% CI, 1.6–3.4]; P = .0005), and 24 hours (4.1 [95% CI, 3.3–4.9] vs 1.3 [95% CI, 1.0–2.8]; P = .0006). They also reported taking fewer cumulative doses of pain medication at 6 hours (1.07 [95% CI, 0.69–1.45] vs 0.39 [95% CI, 0.2–0.58]; P = .003), 24 hours (2.63 [95% CI, 1.95–3.31] vs 1.37 [95% CI, 0.92–1.82]; P = .004), and 48 hours (4.07 [95% CI, 2.9–5.24] vs 2.19 [95% CI, 1.44–2.94]; P = .009). There was no difference in time missed from work between the auricular acupuncture and standard therapy groups. Conclusions: Compared with usual treatment, battlefield auricular acupuncture was associated with reduced sore throat pain for 24 hours and decreased use of pain medication for up to 48 hours. There was no apparent effect on hours missed from work.